Heska (HSKA) Gross Profit Margin starting from the first quarter 2023 to first quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Heska Corporation  (NASDAQ: HSKA)


Heska's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HSKA Gross Profit Margin (Mar 31 2023)
Q1 		(Dec 31 2022)
Q4 		(Sep 30 2022)
Q3 		(Jun 30 2022)
Q2 		(Mar 31 2022)
Q1
Y / Y Revenue Change -3.73 %
Seq. Revenue Change -5.96 %
Revenue In Millions $62.38
Gross Profit Margin 43.92 %
Gross Profit Margin Total Ranking # 2111
Gross Profit In Millions $27.40
Y / Y Gross Profit Change -5.99 %
Seq. Gross Profit Change -1.51 %


Commenting First Quarter 2023 Gross Profit Margin
Heska Corporation increased Gross Profit Margin through reduction in Cost of Sales and despite contraction in Gross Profit by -1.51 % and Revenue by -5.96 %. Gross Profit Margin in Q1 was 43.92 %, above company average.


Observing first quarter 2023 results within In Vitro & In Vivo Diagnostic Substances industry 5 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2111, from total ranking in the previous quarter at 2220.
Learn about Gross Margin
HSKA's Gross Profit Margin first quarter 2023 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 6
Healthcare Sector # 389
Overall # 2077

Gross Profit Margin Statistics
High Average Low
47.79 % 42.29 % 27.49 %
(Sep 30 2018)   (Jun 30 2013)


HSKA Gross Income Trends • More of HSKA's Profitabilty Ratios • HSKA Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
HSKA's Cumulative Gross Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
HSKA's Gross Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for HSKA's Competitors
Gross Profit Margin Profit Margin for Heska's Suppliers
Gross Profit Margin Profit Margin for HSKA's Customers

You may also want to know
HSKA's Annual Growth Rates HSKA's Profitability Ratios HSKA's Asset Turnover Ratio HSKA's Dividend Growth
HSKA's Roe HSKA's Valuation Ratios HSKA's Financial Strength Ratios HSKA's Gross Profit Growth
HSKA's Roa HSKA's Inventory Turnover Ratio HSKA's Growth Rates HSKA's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2023, within In Vitro & In Vivo Diagnostic Substances Industry Gross Profit MarginMar 31 2023 MRQ Gross ProfitMar 31 2023 MRQ Revenue
Myriad Genetics Inc   67.33 %$ 122.000  Millions$ 181.200  Millions
Idexx Laboratories Inc  60.32 %$ 542.971  Millions$ 900.195  Millions
Quidelortho Corp  53.02 %$ 448.600  Millions$ 846.100  Millions
Aspira Women s Health inc   51.42 %$ 1.191  Millions$ 2.316  Millions
Neogen Corporation  49.47 %$ 107.964  Millions$ 218.255  Millions
Heska Corporation  43.92 %$ 27.399  Millions$ 62.381  Millions
Alpha Teknova Inc   26.57 %$ 2.423  Millions$ 9.121  Millions
Lantheus Holdings Inc   25.63 %$ 77.076  Millions$ 300.784  Millions
Biomerica Inc   10.82 %$ 0.120  Millions$ 1.111  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.